211 related articles for article (PubMed ID: 24929344)
1. Synthesis and identification of cytotoxic diphyllin glycosides as vacuolar H(+)-ATPase inhibitors.
Zhang Z; Ma J; Zhu L; Zhao Y
Eur J Med Chem; 2014 Jul; 82():466-71. PubMed ID: 24929344
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of Cleistanthin A Derivatives as Potent Vacuolar H(+) -ATPase Inhibitors.
Zhao Y; Lu Y; Ma J; Zhu L
Chem Biol Drug Des; 2015 Oct; 86(4):691-6. PubMed ID: 25677205
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and bioevaluation of heterocyclic derivatives of Cleistanthin-A.
Zhao Y; Zhang R; Lu Y; Ma J; Zhu L
Bioorg Med Chem; 2015 Aug; 23(15):4884-4890. PubMed ID: 26059594
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel lignan glycosides as anticancer agents.
Wang Y; Xia C; Zhang W; Zhao Y
Chem Biol Drug Des; 2016 Oct; 88(4):562-7. PubMed ID: 27160642
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and bioevaluation of diphyllin glycosides as novel anticancer agents.
Zhao Y; Ni C; Zhang Y; Zhu L
Arch Pharm (Weinheim); 2012 Aug; 345(8):622-8. PubMed ID: 22592997
[TBL] [Abstract][Full Text] [Related]
6. 2, 4, 5-Trideoxyhexopyranosides derivatives of diphyllin: Synthesis and anticancer activity.
Cai R; Li Y; Zhu L; Wei C; Bao X; Zhao Y
Chem Biol Drug Des; 2022 Aug; 100(2):256-266. PubMed ID: 35614538
[TBL] [Abstract][Full Text] [Related]
7. ZT-25, a new vacuolar H(+)-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells.
Lu Y; Zhang R; Liu S; Zhao Y; Gao J; Zhu L
Eur J Pharmacol; 2016 Jan; 771():130-8. PubMed ID: 26689625
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
[TBL] [Abstract][Full Text] [Related]
9. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxicity and anti-invasion activity of three natural diphyllin L-arabinopyranosides.
Cai R; Zhu L; Shen W; Zhao Y
Fitoterapia; 2019 Sep; 137():104198. PubMed ID: 31175951
[TBL] [Abstract][Full Text] [Related]
11. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
[TBL] [Abstract][Full Text] [Related]
12. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
Niikura K; Takano M; Sawada M
Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines.
Supino R; Scovassi AI; Croce AC; Dal Bo L; Favini E; Corbelli A; Farina C; Misiano P; Zunino F
Ann N Y Acad Sci; 2009 Aug; 1171():606-16. PubMed ID: 19723111
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of genotoxic and anti-mutagenic properties of cleistanthin A and cleistanthoside A tetraacetate.
Himakoun L; Tuchinda P; Puchadapirom P; Tammasakchai R; Leardkamolkarn V
Asian Pac J Cancer Prev; 2011; 12(12):3271-5. PubMed ID: 22471465
[TBL] [Abstract][Full Text] [Related]
15. V-ATPase as an effective therapeutic target for sarcomas.
Perut F; Avnet S; Fotia C; Baglìo SR; Salerno M; Hosogi S; Kusuzaki K; Baldini N
Exp Cell Res; 2014 Jan; 320(1):21-32. PubMed ID: 24416789
[TBL] [Abstract][Full Text] [Related]
16. Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection.
Hu CJ; Chen YT; Fang ZS; Chang WS; Chen HW
Int J Nanomedicine; 2018; 13():8579-8593. PubMed ID: 30587980
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Cytotoxicity, Anti-Migration and Anti-Invasion Activity of Diphyllin Heterocyclic Derivatives.
Shen W; Chen H; Wu M; Zhang T; Zhu L; Zhao Y
Med Chem; 2022; 18(1):122-129. PubMed ID: 33349219
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H
Lindstrom A; Anantpadma M; Baker L; Raghavendra NM; Davey R; Davisson VJ
ChemMedChem; 2018 Dec; 13(24):2664-2676. PubMed ID: 30335906
[TBL] [Abstract][Full Text] [Related]
19. Effects of diphyllin as a novel V-ATPase inhibitor on gastric adenocarcinoma.
Shen W; Zou X; Chen M; Liu P; Shen Y; Huang S; Guo H; Zhang L
Eur J Pharmacol; 2011 Sep; 667(1-3):330-8. PubMed ID: 21645513
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and cytotoxic activity evaluation of new aminosubstituted benzofurans.
Daniilides K; Lougiakis N; Pouli N; Marakos P; Samara P; Tsitsilonis O
Med Chem; 2014; 10(6):619-27. PubMed ID: 24047215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
